microRNA: Cancer, 1st ed. 2015
From Molecular Biology to Clinical Practice

Advances in Experimental Medicine and Biology Series, Vol. 889

Coordinator: Santulli Gaetano

Language: English

105.49 €

In Print (Delivery period: 15 days).

Add to cartAdd to cart
microRNA: Cancer
Publication date:
235 p. · 15.5x23.5 cm · Paperback

105.49 €

In Print (Delivery period: 15 days).

Add to cartAdd to cart
microRNA: Cancer
Publication date:
Support: Print on demand

This volume thoroughly explores of the functional role of microRNAs in cancer. It not only expertly describes the molecular mechanisms underlying the malignant transformation process but also compiles cutting-edge research on microRNAs in several forms of cancer, including colorectal cancer, pancreatic cancer, leukemia/lymphoma, prostate cancer, lung cancer, ovarian cancer, and bone cancer. Distinguished experts, currently working in prestigious institutions, elegantly discuss these fundamental themes. The text, which opens with a foreword by the renowned Dr. Carlo M. Croce, is enhanced by abundant color photographs, schemes, diagrams, and tables that fully support and complement the content.

microRNA: Cancer is an ideal companion to both microRNA: Basic Science andmicroRNA: Medical Evidence. Taken together, these three books provide a state-of-the-art overview of this rapidly-expanding and fascinating field, from the molecular level to clinical practice. It will be invaluable to medical students, physicians, and researchers, as a complete and unique guide in the exploration of microRNA in basic science, cancer and clinical practice.

1) microRNA: the master key to precision medicine.- 2) MICRORNAS IN THE MALIGNANT TRANSFORMATION PROCESS.- 3) microRNA and chronic lymphocytic leukemia.- 4) microRNA and malignant lymphoma.- 5) microRNA and gastrointestinal stromal cancer.- 6) microRNA and pancreatic cancer.- 7) microRNA and colorectal cancer.- 8) microRNA and prostate cancer.- 9) Ovarian cancer.- 10) microRNA and breast cancer.- 11) microRNA and soft tissue sarcoma.- 12) microRNA and bone cancer.

Dr. Gaetano Santulli received his MD and PhD at the University of Naples “Federico II”. A physician scientist, Dr. Santulli completed his postdoctoral training at Columbia University Medical Center in New York City, supported by an AHA fellowship and a Scientist Development Grant. Cardiologist, he authored more than 100 publications, including peer-reviewed articles in high impact journals, book chapters, and medical books. He is currently a faculty member of Columbia University. He lives in Manhattan.

Dr. Santulli’s expertise comprises both clinical and basic research topics, including hypertension, diabetes, angiogenesis, heart failure, arrhythmias, vascular disorders, and skeletal muscle disease. He is a member of several international academic societies, including New York Academy of Sciences, American Heart Association (AHA), American Diabetes Association, European Society of Cardiology, Endocrine Society, American Association for the Advancement of Science, European Association of Heart Failure, European Association of Echocardiography, Acute Cardiovascular Care Association, European Association of Percutaneous Cardiovascular Interventions. He serves on the Editorial Boards of numerous medical Journals.

Provides a systematic and extensive discussion of microRNA's role in various types of cancer Chapter authors are distinguished experts in each clinical field and are from prominent universities and institutions Comprehensively examines microRNA's role in eleven of the most prevalent forms of cancer